Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.92 |
| ▸ | TDP1 | Q9NUW8 | 8/20 | 0.92 |
| ▸ | TSHR | P16473 | 5/20 | 0.92 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.92 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.92 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.92 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.92 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.92 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.92 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.92 |
| ▸ | HTR2B | P41595 | 1/20 | 0.92 |
| ▸ | MAPT | P10636 | 6/20 | 0.75 |
| ▸ | MEN1 | O00255 | 5/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.75 |
| ▸ | AR | P10275 | 1/20 | 0.75 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diphenylamine SCHEMBL229 | 1.00 | HSD17B10 (1.00) | HSD17B10ALDH1A1TDP1TSHRALOX12 | |
| Diphenylamine SCHEMBL3003404 | 1.00 | HSD17B10 (1.00) | HSD17B10ALDH1A1TDP1TSHRALOX12 | |
| Diphenylamine SCHEMBL6828443 | 1.00 | HSD17B10 (1.00) | HSD17B10ALDH1A1TDP1TSHRALOX12 | |
| Diphenylamine SCHEMBL1619083 | 1.00 | HSD17B10 (1.00) | HSD17B10ALDH1A1TDP1TSHRALOX12 | |
| Diphenylamine SCHEMBL23295988 | 0.96 | HSD17B10 (0.92) | HSD17B10ALDH1A1TDP1TSHRALOX12 | |
| Diphenylamine SCHEMBL634477 | 0.96 | HSD17B10 (0.92) | HSD17B10ALDH1A1TDP1TSHRALOX12 | |
| Diphenylamine SCHEMBL192934 | 0.96 | HSD17B10 (0.92) | HSD17B10ALDH1A1TDP1TSHRALOX12 | |
| Diphenylamine SCHEMBL3357779 | 0.96 | HSD17B10 (0.92) | HSD17B10ALDH1A1TDP1TSHRALOX12 | |
| SCHEMBL9480038 | 0.96 | ALDH1A1 (1.00) | HSD17B10ALDH1A1TDP1TSHRALOX12 | |
| Diphenylamine SCHEMBL9362761 | 0.96 | HSD17B10 (0.92) | HSD17B10ALDH1A1TDP1TSHRALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107445886-A | A kind of preparation method of the phenyl carbazole of 3 bromine of high-purity 9 | 北京八亿时空液晶科技股份有限公司 | 2017-12-08 | — | — | CN | claimed |
| EP-1735412-B1 | KETONE DIARYLAMINE CONDENSATES | CHEMTURA CORP (US) | 2012-03-14 | — | — | EP | claimed |
| CN-111088183-B | Marine vibrio and application thereof in preparation of iota-carrageenase with thermal stability | 青岛大学 | 2021-07-13 | — | — | CN | disclosed |
| US-11062794-B2 | Olfactory signature and odorant mixture having the same | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2021-07-13 | — | — | US | disclosed |
| CN-109735520-B | Iota-carrageenase with thermal stability and application thereof | 青岛大学 | 2020-06-05 | — | — | CN | disclosed |
| CN-109762799-B | Kappa-carrageenase and application thereof | 青岛大学 | 2020-06-05 | — | — | CN | disclosed |
| CN-111088183-A | Marine vibrio and application thereof in preparation of iota-carrageenase with thermal stability | 青岛大学 | 2020-05-01 | — | — | CN | disclosed |
| CN-111004755-A | Citrobacter T26 for specifically degrading hyaluronic acid, hyaluronidase HylC produced by Citrobacter T26 and application of hyaluronidase HylC | 中国海洋大学 | 2020-04-14 | — | — | CN | disclosed |
| US-20180253534-A1 | OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2018-09-06 | — | — | US | disclosed |
| WO-2013035070-A1 | OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2013-03-14 | — | — | WO | disclosed |